These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 14986278

  • 1. Nucleoside-related mitochondrial toxicity among HIV-infected patients receiving antiretroviral therapy: insights from the evaluation of venous lactic acid and peripheral blood mitochondrial DNA.
    Montaner JS, Côté HC, Harris M, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV.
    Clin Infect Dis; 2004 Mar 01; 38 Suppl 2():S73-9. PubMed ID: 14986278
    [Abstract] [Full Text] [Related]

  • 2. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.
    Côté HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O'Shaughnessy MV, Montaner JS.
    N Engl J Med; 2002 Mar 14; 346(11):811-20. PubMed ID: 11893792
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.
    Montaner JS, Côté HC, Harris M, Hogg RS, Yip B, Chan JW, Harrigan PR, O'Shaughnessy MV.
    J Acquir Immune Defic Syndr; 2003 Sep 14; 34 Suppl 1():S85-90. PubMed ID: 14562863
    [Abstract] [Full Text] [Related]

  • 7. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy.
    Miura T, Goto M, Hosoya N, Odawara T, Kitamura Y, Nakamura T, Iwamoto A.
    J Med Virol; 2003 Aug 14; 70(4):497-505. PubMed ID: 12794710
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.
    Gingelmaier A, Grubert TA, Kost BP, Setzer B, Lebrecht D, Mylonas I, Mueller-Hoecker J, Jeschke U, Hiedl S, Friese K, Walker UA.
    Antivir Ther; 2009 Aug 14; 14(3):331-8. PubMed ID: 19474467
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment.
    Noguera A, Fortuny C, Sanchez E, Artuch R, Vilaseca MA, Muñoz-Almagro C, Pou J, Jiménez R.
    Pediatr Infect Dis J; 2003 Sep 14; 22(9):778-82. PubMed ID: 14506367
    [Abstract] [Full Text] [Related]

  • 15. Noninvasive diagnosis of mitochondrial dysfunction in HAART-related hyperlactatemia.
    Garrabou G, Sanjurjo E, Miró O, Martínez E, Infante AB, López S, Cardellach F, Gatell JM, Casademont J.
    Clin Infect Dis; 2006 Feb 15; 42(4):584-5. PubMed ID: 16421815
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mitochondrial DNA and nucleoside toxicity.
    Casademont J, Miró O, Cardellach F.
    N Engl J Med; 2002 Jul 18; 347(3):216-8; author reply 216-8. PubMed ID: 12125711
    [No Abstract] [Full Text] [Related]

  • 19. Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens.
    Côté HC, Yip B, Asselin JJ, Chan JW, Hogg RS, Harrigan PR, O'Shaughnessy MV, Montaner JS.
    J Infect Dis; 2003 Jun 15; 187(12):1972-6. PubMed ID: 12792876
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.